IRIS PubliCatt

Bosello, Silvia Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.771
NA - Nord America 2.730
AS - Asia 554
AF - Africa 16
OC - Oceania 10
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 6.100
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.716
DE - Germania 910
SE - Svezia 470
IT - Italia 455
CN - Cina 330
UA - Ucraina 226
FR - Francia 222
IE - Irlanda 174
IN - India 101
GB - Regno Unito 99
PL - Polonia 68
FI - Finlandia 59
TR - Turchia 44
BE - Belgio 34
IR - Iran 20
SG - Singapore 18
HK - Hong Kong 17
CA - Canada 13
CI - Costa d'Avorio 11
JP - Giappone 11
AU - Australia 10
RU - Federazione Russa 9
RO - Romania 8
NL - Olanda 7
CZ - Repubblica Ceca 6
ES - Italia 6
EU - Europa 6
DK - Danimarca 5
CO - Colombia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
CH - Svizzera 3
MY - Malesia 3
NG - Nigeria 3
BG - Bulgaria 2
CL - Cile 2
HU - Ungheria 2
SA - Arabia Saudita 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
KR - Corea 1
LU - Lussemburgo 1
MD - Moldavia 1
PK - Pakistan 1
TH - Thailandia 1
TW - Taiwan 1
UG - Uganda 1
Totale 6.100
Salva come PNG Salva come JPEG
Città #
Chandler 590
Ashburn 211
Ann Arbor 173
Dublin 173
Jacksonville 132
Dearborn 121
San Mateo 96
Wilmington 88
Woodbridge 84
Nanjing 82
New York 78
Houston 72
Milan 66
Seattle 66
Kraków 64
Fairfield 61
Rome 60
Nürnberg 48
Boston 46
Lawrence 42
Marseille 42
Izmir 39
Beijing 38
Cattolica 37
Bremen 34
Nanchang 34
Brussels 33
Munich 32
Pune 31
Redwood City 28
Princeton 25
Hebei 23
Norwalk 23
Kunming 20
Guangzhou 18
Boardman 17
Lancaster 17
Leawood 16
Tianjin 16
Trieste 16
Augusta 15
Cambridge 15
Falls Church 15
Fremont 15
Hong Kong 14
Andover 13
Chicago 13
Detroit 12
Abidjan 11
Helsinki 11
Mountain View 11
Redmond 11
University Park 11
Hangzhou 10
Jiaxing 10
Singapore 10
Shenyang 9
Zhengzhou 9
Changsha 8
Florence 8
Kish 8
Los Angeles 8
Hefei 7
London 7
Shanghai 7
Monmouth Junction 6
Paris 6
Ardabil 5
Ferrara 5
Fuzhou 5
Palermo 5
Rozzano 5
Tokyo 5
Toronto 5
Brno 4
Busto Arsizio 4
Changchun 4
Enterprise 4
Jinan 4
Phoenix 4
Rivignano 4
Toowoomba 4
Washington 4
Campolongo Maggiore 3
Chengdu 3
Clearwater 3
Copenhagen 3
Frankfurt am Main 3
Hounslow 3
Kuala Lumpur 3
Lagos 3
Lanzhou 3
Lappeenranta 3
Melbourne 3
Nancy 3
Ningbo 3
Philadelphia 3
Prato 3
Simi Valley 3
Terni 3
Totale 3.294
Salva come PNG Salva come JPEG
Nome #
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 316
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 232
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 184
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 174
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 160
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 156
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 135
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 129
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 126
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 124
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 124
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 123
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 117
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 115
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 111
(AS) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. 109
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 108
Assessment of neurological manifestations in hospitalized patients with COVID-19 108
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 107
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 104
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 104
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 102
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 102
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 98
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 97
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 91
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 90
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 89
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 80
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 80
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 78
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 78
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 75
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 75
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 74
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 71
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 70
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 68
Sarilumab use in severe SARS-CoV-2 pneumonia 68
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 66
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 65
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 64
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 64
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 61
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 60
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 59
Adult-onset Still's disease following COVID-19 vaccination 58
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 57
Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests 55
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 55
Troponin in Stable Ischemic Heart Disease and Diabetes 54
Troponin in Stable Ischemic Heart Disease and Diabetes 52
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 48
An unusual lung involvement in scleroderma: lipoid pneumonia 48
Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study 47
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 45
Arthritis in systemic vasculitis: a retrospective analysis 45
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 45
FUNZIONE CARDIORESPIRATORIA, ARTERIAL STIFFNESS E LIVELLI DI NT-PRO BNP IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE ALL’ESORDIO 44
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases 44
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 39
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 37
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 36
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 34
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 34
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 32
Reply to: Individuality of the composition of the human microbiota 29
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 27
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 24
Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic 17
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? 17
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 16
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 16
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease 14
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 14
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 13
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 12
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 11
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 10
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 10
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 10
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 10
More to B: the growing evidence to inform targeting B cells in scleroderma 10
Comment on: Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis 9
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 9
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 9
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 9
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 9
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 8
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 8
Environmental Pollution by Benzene and PM10 and Clinical Manifestations of Systemic Sclerosis: A Correlation Study 8
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 8
COVID-19 and intestinal inflammation: Role of fecal calprotectin 8
Correspondence to 'Gender gap in rheumatology: speaker representation at annual conferences' by Monga and Liew-gender discrepancies at annual EULAR congresses: towards the gap narrowing 7
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 7
Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype 7
Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios 7
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 6
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency 5
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 5
Totale 6.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.569
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019102 0 0 0 0 0 0 0 0 0 0 72 30
2019/2020827 131 42 48 29 72 128 79 30 30 63 124 51
2020/2021747 29 54 197 49 87 21 51 20 87 28 107 17
2021/2022800 54 38 23 56 61 44 36 102 39 86 106 155
2022/20231.683 214 235 127 271 83 191 83 138 152 14 56 119
2023/2024795 35 273 51 55 38 144 71 73 20 30 5 0
Totale 6.266